The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis
Watts L., Karaderi T., Roberts A., Appleton L., Wordsworth T., Cohen C., Wordsworth P., Vecellio M.